FIELD: pharmaceuticals.
SUBSTANCE: invention relates to compounds of formula 1, where R2 and R3 are defined in the claims, or their pharmaceutically acceptable salts, methods of their preparation, pharmaceutical compositions containing them, and the use of compounds for the treatment and prevention of FAP-mediated diseases.
R1 is selected from:
EFFECT: obtaining pyrrolidine and piperidine compounds.
11 cl, 8 tbl, 439 ex
| Title | Year | Author | Number |
|---|---|---|---|
| OXAZOLIDINE-BASED COMPOUND AND ANDROGEN RECEPTOR SELECTIVE AGONIST | 2015 |
|
RU2702001C2 |
| DIAMINOPYRIMIDINE DERIVATIVES AND METHODS FOR PRODUCTION THEREOF | 2012 |
|
RU2587493C2 |
| NEW PHTHALAZINE DERIVATIVES AND ITS PRODUCTION PROCESS | 2014 |
|
RU2636585C2 |
| DIAMINOPYRIMIDINE DERIVATIVES AND METHODS FOR PRODUCTION THEREOF | 2012 |
|
RU2587981C2 |
| PIPERIDINE COMPOUNDS, PHARMACEUTICAL COMPOSITION CONTAINING THEREIN AND ITS APPLICATION | 2009 |
|
RU2514827C2 |
| NEW ANTI-DIABETIC AGENTS | 2000 |
|
RU2265012C2 |
| BENZOTHIAZOLE COMPOUNDS AND METHODS FOR THEIR USE FOR TREATMENT OF NEURODEGENERATIVE DISORDERS | 2018 |
|
RU2778370C2 |
| NOVEL PYRIDOPYRIMIDINONE COMPOUNDS FOR MODULATION OF CATALYTIC ACTIVITY OF HISTONE LYSINE DEMETHYLASES (KDMS) | 2015 |
|
RU2684396C2 |
| TLR7/8 ANTAGONISTS AND THEIR APPLICATION | 2017 |
|
RU2758686C2 |
| ISOQUINOLINONE DERIVATIVES, METHOD FOR PRODUCTION THEREOF AND PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING DISEASES ASSOCIATED WITH POLY(ADP-ribose)POLYMERASE-1, CONTAINING THEM AS ACTIVE INGREDIENT | 2020 |
|
RU2815480C1 |
